Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007
December 26, 2019
Novocure to Participate in the 38th Annual J.P. Morgan Healthcare Conference
December 2, 2019
Novocure and the AACR Announce 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
November 26, 2019
Novocure to Participate in the Evercore ISI 2019 HealthCONx Conference
November 20, 2019
Novocure Announces 43 Presentations on Tumor Treating Fields at 24th Annual Meeting of the Society for Neuro-Oncology
October 31, 2019
Novocure Reports Third Quarter 2019 Financial Results and Provides Company Update
October 16, 2019
Results from STELLAR Trial of Tumor Treating Fields with Chemotherapy in Malignant Pleural Mesothelioma Published in The Lancet Oncology
October 1, 2019
Novocure to Report Third Quarter 2019 Financial Results
September 9, 2019
Novocure Announces 27 Presentations at the American Society for Radiation Oncology 2019 Annual Meeting
August 12, 2019
China National Medical Products Administration Grants Innovative Medical Device Designation for Optune® in China
August 6, 2019
Novocure to Participate in Three Upcoming Investor Conferences
July 25, 2019
Novocure Reports Second Quarter 2019 Financial Results and Provides Company Update
July 22, 2019
Novocure Announces 10 Oral Presentations and a Special Session on Tumor Treating Fields at the 41st International Engineering in Medicine and Biology Conference
July 18, 2019
CMS Establishes 2019 Monthly Fee Schedule Amount for Optune®
July 18, 2019
Medicare Releases Final Local Coverage Determination Providing Coverage of Optune® for Newly Diagnosed Glioblastoma
July 2, 2019
Novocure to Report Second Quarter 2019 Financial Results
June 26, 2019
German Institute for Quality and Efficiency in Healthcare Publishes Rapid Report Noting Optune’s Survival Benefit for Patients with Newly Diagnosed Glioblastoma
May 24, 2019
Novocure to Participate in the Jefferies 2019 Global Healthcare Conference
May 23, 2019
FDA Approves the NovoTTF-100LTM System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma
May 10, 2019
Medicare Issues Proposed Local Coverage Determination that Provides Coverage of Optune® for Newly Diagnosed Glioblastoma
May 2, 2019
Novocure Reports First Quarter 2019 Financial Results and Provides Company Update
April 30, 2019
Novocure Announces the International Journal of Radiation Oncology, Biology, Physics Publishes Data Demonstrating Higher Doses of Tumor Treating Fields Improved Survival of Newly Diagnosed Glioblastoma Patients
April 15, 2019
Novocure Publishes 2018 Annual Report Featuring Company’s Vision, Mission and Values
April 3, 2019
Inaugural AACR-Novocure Tumor Treating Fields Research Grant Recipients Announced at AACR Annual Meeting 2019
April 2, 2019
Novocure to Report First Quarter 2019 Financial Results
March 22, 2019
Novocure Initiates Phase 3 Pivotal Trial in Recurrent Ovarian Cancer
March 21, 2019
Novocure Announces 48 Presentations and a Symposium Session on Tumor Treating Fields at the American Association for Cancer Research Annual Meeting 2019
March 21, 2019
Novocure’s Chief Science Officer Retires after 17 Years of Service
March 18, 2019
Novocure to Participate in Oppenheimer’s 29th Annual Healthcare Conference
February 28, 2019
Novocure Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Company Update
January 7, 2019
Novocure Announces Fourth Quarter and Full Year 2018 Operating Statistics, Preliminary Net Revenues and Provides Company Update